Page results
-
RNOH are pleased to launch a series of regular Health and Wellbeing Information and Support Sessions to support patients following a cancer diagnosis and also during/after treatment. Theseā¦
-
The UCLH@Home service is helping patients like 55-year-old Sherena Kranat to continue their recovery in their own home under the care of their hospital team.
-
A team at UCLH and UCL have developed new methods to predict outcomes for pregnancies where there are issues with poor growth of the baby inside the womb.
-
The psychology team will be running this 8-week online parent mindfulness group for parents of children and young people under a medical team at UCLH.
-
We have been informed that there has been an increasing number of fractures in the battery securing parts of this pump. During the insulin pump use, if the device is dropped or excessive force is applied, some of the device's battery securing parts may break.
-
This is an 8-week online parent group led by the Child Wellbeing Practitioners at UCLH.
-
In the UK in 2020, 23 million Novo Nordisk FlexPen and FlexTouch pre-filled devices were incinerated or sent to landfill as there was no viable recycling alternative.
-
Pioneering neurologist who worked at NHNN is commemorated with an English Heritage London blue plaque at his Wimpole Street home where he had his private practice.
-
UCLH is reminding staff that gloves are not always required, by reducing the instances where non-sterile plastic gloves are used when treating non-infectious patients. The focus is now on how clean hands are just as effective a barrier against infection.
-
All medications given to you while you are an inpatient are provided free of charge. At follow-up appointments, you may be given a prescription by your doctor or nurse. This must be collected from the hospital pharmacy; you cannot take it to your local chemist. There is a standard prescription charge per item which you can pay for by cash or card.
File results
-
FOI/2023/0247 - Treatment guidelines for Idiopathic Pulmonary Fibrosis
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI/2023/0249 - Treatments for clotting disorders - Haemophilia B, Von Willebrand Disease
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI/2023/0360 - Minutes of Board of Director meetings and Declarations of Interests (DoI) statements 2008-2023
-
FOI/2023/0352 - Security training/ Data breaches/ Security budgets/ Digital cyber security services
-
FOI/2023/0280 - Psychiatric inpatient wards - parental and family